FIELD: organic chemistry, biochemistry, peptides. SUBSTANCE: invention describes derivatives of octreotide of the general formula (I) where (D)A means residue D-(Nindole-formyl)-tryptophane; R1 means hydrogen atom or tert. -butoxycarbonyl group either group of species CO-OX1 where X1 can mean the following values: 2-alkylsulfonylethyl, 2-phenyl-sulfonylethyl, 2-(4-substituted aryl)-sulfonylethyl; R2 means CO-OX2 where X2 can mean the following values: 2-alkylsulfonylethyl, 2-phenylsulfonylethyl, 2-(4- substituted aryl)-sulfonylethyl; R3 and R4 mean simultaneously values -CH2-NH-CO-Y where Y means methyl, C1-C5-alkyl, phenyl, substituted phenyl or in common they form disulfide bond; R5 means hydrogen atom or group of species CO-OX3 where X3 can mean the following values: 2- alkylsulfonylethyl, 2-phenyl-sufonylethyl, 2-(4-substituted aryl)-sulfonylethyl. New protected derivatives of octreotide are parent compounds for the more effective and simple synthesis of octreotide with the enhanced yield. EFFECT: improved method of synthesis. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PROTECTED CALCITONINE PEPTIDES | 2000 |
|
RU2193567C2 |
METHOD FOR PRODUCING CYCLIC PEPTIDE-OCTREOTIDE | 2010 |
|
RU2435780C1 |
RGD-CONTAINING PEPTIDES | 2001 |
|
RU2214416C2 |
PROTECTED DERIVATIVES OF VASOPRESSIN | 1997 |
|
RU2123498C1 |
PEPTIDE AND A METHOD OF ITS SYNTHESIS | 1994 |
|
RU2067000C1 |
CYCLIC OCTAPEPTIDE, RADIOPHARMACEUTICAL AGENT BASED THEREON AND METHOD OF USING RADIOPHARMACEUTICAL AGENT TO PRODUCE MEDICINAL (PHARMACEUTICAL) AGENTS FOR TREATING NEOPLASMS EXPRESSING SOMATOSTATIN RECEPTORS | 2013 |
|
RU2528414C1 |
METHOD OF PRODUCING CYCLIC PEPTIDE | 2010 |
|
RU2494105C2 |
SHORT PEPTIDES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2648357C2 |
PROTECTED OXYTOCIN DERIVATIVES | 1997 |
|
RU2125062C1 |
OCTAPEPTIDE FOR PRODUCING RADIOTRACERS, RADIOTRACER BASED THEREON METHOD OF DIAGNOSING TUMOURS, EXPRESSING SOMATOSTATIN RECEPTORS | 2011 |
|
RU2457215C1 |
Authors
Dates
2003-01-10—Published
2001-05-14—Filed